S C Schachater

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Botanicals and herbs: a traditional approach to treating epilepsy
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Neurotherapeutics 6:415-20. 2009
  2. ncbi request reprint Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Res 50:67-70. 2002
  3. ncbi request reprint Epilepsy
    S C Schachater
    Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Neurol Clin 19:57-78. 2001
  4. ncbi request reprint Pharmacology and clinical experience with tiagabine
    S C Schachter
    Office of Clinical Trials and Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Expert Opin Pharmacother 2:179-87. 2001
  5. ncbi request reprint Remacemide: current status and clinical applications
    S C Schachter
    Departments of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Expert Opin Investig Drugs 9:871-83. 2000
  6. ncbi request reprint Drug-mediated antiepileptogenesis in humans
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Neurology 59:S34-5. 2002
  7. ncbi request reprint A patient with a new-onset seizure after a stroke
    Steven C Schachter
    Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Behav 4:S23-6; discussion S27-8. 2003
  8. ncbi request reprint Improving quality of life beyond seizure control
    Steven C Schachter
    Comprehensive Epilepsy Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Epileptic Disord 7:S34-8. 2005
  9. ncbi request reprint Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors
    Steven C Schachter
    Harvard Medical School, Boston, MA 02215, USA
    Expert Rev Neurother 6:111-8. 2006
  10. ncbi request reprint Vagus nerve stimulation: where are we?
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Neurol 15:201-6. 2002

Collaborators

Detail Information

Publications36

  1. doi request reprint Botanicals and herbs: a traditional approach to treating epilepsy
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Neurotherapeutics 6:415-20. 2009
    ..S. Food and Drug Administration in regulating herbal products, and presents the author's approach to the scientific assessment of herbal therapies as potential therapies for patients with epilepsy...
  2. ncbi request reprint Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Res 50:67-70. 2002
    ..This paper suggests methods by which drugs could be tested for antiepileptic properties and reviews whether current antiepilectic drugs (AEDs) are antiepileptic in addition to being effective for seizure suppression...
  3. ncbi request reprint Epilepsy
    S C Schachater
    Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Neurol Clin 19:57-78. 2001
    ....
  4. ncbi request reprint Pharmacology and clinical experience with tiagabine
    S C Schachter
    Office of Clinical Trials and Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Expert Opin Pharmacother 2:179-87. 2001
    ..Open studies confirm that patients with medically refractory partial epilepsy can be successfully converted to TGB monotherapy and that TGB may be effective for other seizure types, such as infantile spasms...
  5. ncbi request reprint Remacemide: current status and clinical applications
    S C Schachter
    Departments of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Expert Opin Investig Drugs 9:871-83. 2000
    ..Adverse effects are related to the gastrointestinal and central nervous systems. RMC is a promising drug with numerous potential applications for both acute or chronic conditions associated with glutamate-mediated neurotoxicity...
  6. ncbi request reprint Drug-mediated antiepileptogenesis in humans
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Neurology 59:S34-5. 2002
    ..e., a cure. Whether any anticonvulsant drugs in current use have antiepileptogenic properties is the subject of this overview...
  7. ncbi request reprint A patient with a new-onset seizure after a stroke
    Steven C Schachter
    Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Behav 4:S23-6; discussion S27-8. 2003
  8. ncbi request reprint Improving quality of life beyond seizure control
    Steven C Schachter
    Comprehensive Epilepsy Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Epileptic Disord 7:S34-8. 2005
    ....
  9. ncbi request reprint Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors
    Steven C Schachter
    Harvard Medical School, Boston, MA 02215, USA
    Expert Rev Neurother 6:111-8. 2006
    ..Irrespective of their level of seizure control from antiepileptic drugs, patients may also benefit from targeted psychosocial interventions that reduce the negative impact of these factors on their quality of life...
  10. ncbi request reprint Vagus nerve stimulation: where are we?
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Neurol 15:201-6. 2002
    ..This review evaluates the role of vagus nerve stimulation in light of recently published research of its mechanism(s) of action, long-term efficacy, safety and tolerability, and application to other disorders besides epilepsy...
  11. ncbi request reprint Comparison of coronal sphenoidal versus standard anteroposterior temporal montage in the EEG recording of temporal lobe seizures
    J R Ives
    Department of Neurology, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA
    Electroencephalogr Clin Neurophysiol 98:417-21. 1996
    ..Indwelling, flexible sphenoidal electrodes assist in ambulatory recording of temporal lobe seizures, both in demonstrating the presence of seizures and in determining the localization and time of seizure onset...
  12. ncbi request reprint High strength stimulation of the vagus nerve in awake humans: a lack of cardiorespiratory effects
    A P Binks
    Physiology Program, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
    Respir Physiol 127:125-33. 2001
    ..With A-fiber threshold established, C-fiber excitation was attempted with physiologically appropriate stimulus parameters (low frequency and high amplitude)...
  13. ncbi request reprint Technical implementation and clinical findings/results of monitoring oxygen saturation in patients referred for long-term EEG monitoring
    J R Ives
    Department of Neurology, Beth Israel Hospital, Boston, MA 02215, USA
    Electroencephalogr Clin Neurophysiol 99:432-9. 1996
    ..From a research aspect, the details of the morphology and timing of the oxygen desaturations and EEG show several interesting relationships with respect to the dynamics of seizure semiology and respiratory physiology...
  14. ncbi request reprint Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures
    S C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Neurology 52:732-7. 1999
    ..To evaluate the efficacy and safety of oxcarbazepine in a placebo-control trial...
  15. ncbi request reprint Increased susceptibility to generalized seizures after immunolesions of the basal forebrain cholinergic neurons in rats
    D C Silveira
    Department of Neurology, Children s Hospital and Harvard Medical School, 300 Longwood Avenue, Enders 320, Boston, MA 02115, USA
    Brain Res 878:223-7. 2000
    ..Lesioned rats had significantly shorter latencies to onset of generalized tonic-clonic seizures than controls. Our findings suggest that basal forebrain cholinergic neurons may participate in the modulation of generalized seizures...
  16. ncbi request reprint Flurothyl-induced seizures in rats activate Fos in brainstem catecholaminergic neurons
    D C Silveira
    Department of Neurology, Beth Israel Deaconess Medical Center, Kirstein 478 and Harvard Medical School, Boston, MA 02115, USA
    Epilepsy Res 39:1-12. 2000
    ..Further studies are necessary to determine whether activation of brainstem catecholaminergic neurons contribute to the autonomic manifestations that frequently accompany epileptic seizures...
  17. ncbi request reprint Management of epilepsy: pharmacologic therapy and quality-of-life issues
    S C Schachter
    Harvard Medical School, Boston, MA, USA
    Postgrad Med 101:133-8, 141-4, 150-3. 1997
    ....
  18. ncbi request reprint Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females
    V L Sheen
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Hum Mol Genet 10:1775-83. 2001
    ..These results demonstrate the sensitivity and specificity of DNA testing for FLN1 mutations and have important functional implications for models of FLN1 protein function in neuronal migration...
  19. ncbi request reprint Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695
    Y Peng
    Center for Neurologic Diseases, Harvard Medical School and Brigham and Women s Hospital, Harvard New Research Building, Room 636F, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
    Neuroscience 150:386-95. 2007
    ....
  20. ncbi request reprint Therapeutic effects of vagus nerve stimulation in epilepsy and implications for sudden unexpected death in epilepsy
    Steven C Schachter
    Harvard Medical School, Dept of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Room K 478, Boston, MA 02215, USA
    Clin Auton Res 16:29-32. 2006
    ..Studies to date of VNS and SUDEP are limited and do not conclusively show an association between VNS and SUDEP rates independent of other epilepsy-specific variables...
  21. doi request reprint Complementary and alternative medical therapies
    Steven C Schachter
    Osher Research Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Neurol 21:184-9. 2008
    ..This review highlights the findings of recently published studies of complementary and alternative medical therapies and epilepsy, and provides an update of the US Food and Drug Administration's role in regulating herbal products...
  22. ncbi request reprint Transcranial magnetic stimulation treatment for epilepsy: can it also improve depression and vice versa?
    Felipe Fregni
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
    Epilepsy Behav 7:182-9. 2005
    ..This article reviews these data and explores further the question of whether depression and epilepsy can be simultaneously treated with TMS for optimal therapeutic impact...
  23. ncbi request reprint Epilepsy: major advances in treatment
    Steven C Schachter
    Harvard Medical School, Boston, Massachusetts, USA
    Lancet Neurol 3:11. 2004
  24. ncbi request reprint Seizure disorders
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Boston, MA, USA
    Prim Care 31:85-94. 2004
  25. ncbi request reprint Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
    ....
  26. ncbi request reprint Vagus nerve stimulation: mood and cognitive effects
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Behav 5:S56-9. 2004
    ..This review evaluates the published evidence for VNS-associated changes in mood and cognition in patients with neuropsychiatric disorders...
  27. ncbi request reprint Vagus nerve stimulation therapy summary: five years after FDA approval
    Steven C Schachter
    Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, 330 Brookline Avenue, KS 457, Boston, MA 02215, USA
    Neurology 59:S15-20. 2002
    ..Additional studies are suggested to further explore the capabilities of VNS therapy...
  28. ncbi request reprint Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005
    Rosemarie Kobau
    Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Hwy, N E, MS K 51, Atlanta, GA 30347, USA
    MMWR Surveill Summ 57:1-20. 2008
    ....
  29. ncbi request reprint Increasing research capacity at the New England School of Acupuncture through faculty and student research training initiatives
    Peter M Wayne
    New England School of Acupuncture NESA, Watertown, Massachusetts, USA
    Altern Ther Health Med 14:52-8. 2008
    ..We discuss successes and challenges encountered in developing and administering these initiatives and the overall impact they have had on research culture and productivity at NESA...
  30. ncbi request reprint Endocrine aspects of epilepsy
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Adv Neurol 90:175-84. 2002
  31. ncbi request reprint Impact of patient-specificity on seizure onset detection performance
    Ali Shoeb
    Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, USA
    Conf Proc IEEE Eng Med Biol Soc 2007:4110-4. 2007
    ....
  32. ncbi request reprint The evolving place of vagus nerve stimulation therapy
    Steven C Schachter
    Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, 330 Brookline Avenue, KS 457, Boston, MA 02215, USA
    Neurology 59:S1-2. 2002
    ..This supplement updates developments with VNS therapy since its approval and suggests future directions for this still-evolving treatment...
  33. ncbi request reprint Currently available antiepileptic drugs
    Steven C Schachter
    Harvard Medical School, Boston, Massachusetts 02215, USA
    Neurotherapeutics 4:4-11. 2007
    ..Consequently, there remains a significant need for further development of new therapies...
  34. ncbi request reprint Lack of herbal supplement characterization in published randomized controlled trials
    Peter M Wolsko
    Kaiser Permanente Medical Group, Denver, CO 80020, USA
    Am J Med 118:1087-93. 2005
    ..We assessed the extent to which recently published randomized controlled trials of herbal supplements characterized and verified the content of the supplement under study...
  35. ncbi request reprint Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004
    ..S. Food and Drug Administration] in the treatment of children and adults with newly diagnosed partial and generalized epilepsies...
  36. ncbi request reprint Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United Stat
    Michael H Cohen
    Harvard Medical School Osher Institute and the Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School, Boston, MA 02215, USA
    Arch Intern Med 165:289-95. 2005
    ..Little is known about policies governing the integration of complementary and alternative medical (CAM) therapies and providers...